Cris Loiren Rodriguez

Array ( [id] => 8452762 [patent_doc_number] => 20120263709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'USE OF IL-33 ANTAGONISTS TO TREAT FIBROTIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/394761 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8044 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007056 [patent_doc_number] => 20110059087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'IL-17 AND IL-23 ANTAGONISTS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/870199 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74825 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059087.pdf [firstpage_image] =>[orig_patent_app_number] => 12870199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586838 [patent_doc_number] => 20130005659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'IL-17 BINDING COMPOUNDS AND MEDICAL USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/392783 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15688 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300980 [patent_doc_number] => 20120183539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Cancer Metastasis Inhibitor' [patent_app_type] => utility [patent_app_number] => 13/387292 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16554 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464597 [patent_doc_number] => 20120269765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'CYTOKINE COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/386652 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28781 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289346 [patent_doc_number] => 20120177672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'THERAPEUTIC PEPTIDES, POLYPEPTIDES AND NUCLEIC ACID SEQUENCES' [patent_app_type] => utility [patent_app_number] => 13/383712 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5842 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615650 [patent_doc_number] => 20100310565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/832311 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39790 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310565.pdf [firstpage_image] =>[orig_patent_app_number] => 12832311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257234 [patent_doc_number] => 08206712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Use of anti-IL-20 antibody for treating rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 12/829697 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4536 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12829697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952353 [patent_doc_number] => 20110033451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/827199 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 36106 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033451.pdf [firstpage_image] =>[orig_patent_app_number] => 12827199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993003 [patent_doc_number] => 20110014656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/828041 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 79303 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014656.pdf [firstpage_image] =>[orig_patent_app_number] => 12828041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201942 [patent_doc_number] => 20110064728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'IL-17 Homologous Polypeptides and Therapeutic Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/825263 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 75678 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064728.pdf [firstpage_image] =>[orig_patent_app_number] => 12825263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234994 [patent_doc_number] => 20100266698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/825208 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 53796 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266698.pdf [firstpage_image] =>[orig_patent_app_number] => 12825208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504613 [patent_doc_number] => 20100260784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PAI-1 BINDING MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/823773 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260784.pdf [firstpage_image] =>[orig_patent_app_number] => 12823773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11428009 [patent_doc_number] => 09566313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Method of treating peripheral vascular diseases using IL-18 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/791052 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11778 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12791052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453970 [patent_doc_number] => 20120264917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'BIPARATOPIC PROTEIN CONSTRUCTS DIRECTED AGAINST IL-23' [patent_app_type] => utility [patent_app_number] => 13/321979 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14933 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928909 [patent_doc_number] => 20110038868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/788129 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 39135 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038868.pdf [firstpage_image] =>[orig_patent_app_number] => 12788129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392035 [patent_doc_number] => 20100303820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHODS OF TREATMENT USING IL-17E ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/787295 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 46930 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303820.pdf [firstpage_image] =>[orig_patent_app_number] => 12787295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343134 [patent_doc_number] => 20100330046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'HUMAN SKIN SUBSTITUTES EXPRESSING IL-12' [patent_app_type] => utility [patent_app_number] => 12/784699 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16614 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330046.pdf [firstpage_image] =>[orig_patent_app_number] => 12784699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054027 [patent_doc_number] => 20120076754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 13/321347 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11131 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076754.pdf [firstpage_image] =>[orig_patent_app_number] => 13321347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016345 [patent_doc_number] => 08137671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Anti-IL-17F antibodies' [patent_app_type] => utility [patent_app_number] => 12/774188 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 30394 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137671.pdf [firstpage_image] =>[orig_patent_app_number] => 12774188 [rel_patent_id] =>[rel_patent_doc_number] =>)